本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Alterity Therapeutics Limited

3.50
+0.10002.94%
盤後3.500.00000.00%16:07 EDT
成交量:9,069.00
成交額:3.10萬
市值:5,181.19萬
市盈率:-2.38
高:3.50
開:3.43
低:3.31
收:3.40
資料載入中...
2024/09/26

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/08/31

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/10/31

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/31

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/08/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/04

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/07/08

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/04

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/25

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/19

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/08

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/23

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/09/15

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/07/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/03/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]